It mimics ghrelin and binds to the ghrelin receptor (GHSR) in the brain, selectively stimulating GH release from the pituitary gland, which increases plasma GH levels
Gozansky, W
6080% adenosylcobalamin) with total stores reaching up to 5 mg (ref1)
Clinical presentation is most commonly with chest pain, but women and patients with diabetes may have atypical symptoms
Biochemistry 53, 61136125 10.1021/bi500389m [DOI] [PubMed] [Google Scholar] 72.Jencks W.P
TL;DR: The GLP-1 receptor agonist landscape in 2026 spans four distinct compounds: semaglutide (selective GLP-1 RA, MW 4113.58 Da, injectable and oral), tirzepatide (dual GLP-1/GIP agonist, MW 4813.45 Da), retatrutide (triple GLP-1/GIP/glucagon agonist, MW ~4500 Da, Phase 3), and orforglipron (non-peptide oral GLP-1 agonist, MW 541.65 Da, FDA-approved April 2026)